A Case with Upper Gastrointestinal Bleeding after Radiofrequency Catheter Ablation.

Yang Tai,Huan Tong,Chengwei Tang
DOI: https://doi.org/10.1053/j.gastro.2017.09.013
IF: 29.4
2018-01-01
Gastroenterology
Abstract:Question: A 58-year-old man complained of hematemesis for several hours. He had also suffered from fever and dizziness intermittently for one week. In addition, he underwent radiofrequency catheter ablation (RFCA) for drug-refractory chronic atrial fibrillation 16 days before the admission. Oral warfarin was administered after RFCA but without monitoring. No gastrointestinal bleeding and use of glucocorticoid or nonsteroidal anti-inflammatory drugs were included in his previous history. On admission, the patient's vital signs included a temperature of 37°C, blood pressure of 116/70 mm Hg, and heart rate of 110 bpm. Laboratory data indicated a decrease in the hemoglobin level to 86 g/L (normal, 130-175 g/L) with an elevated prothrombin time of 30.5 s (normal, 9.6-12.8 s) and an International Normalized Ratio of 2.63 (normal, 0.86-1.14). Liver and renal function tests were normal. The gastrointestinal hemorrhage was first considered to be anticoagulant-associated, therefore, warfarin was discontinued, and vitamin K1 and esomeprazole were administered. However, the patient still presented repeated hematemesis. At 12 hours after admission, his hemoglobin level decreased to 71 g/L, and an urgent esophagogastroduodenoscopy was performed, which indicated a defective lesion on the anterior esophageal wall with oozing blood (Figure A, B). What is the defective lesion on the anterior esophageal wall? How to treat it? See the Gastroenterology web site (www.gastrojournal.org) for more information on submitting your favorite image to Clinical Challenges and Images in GI. Computed tomography revealed leakage of the contrast medium into the esophagus from the left inferior pulmonary vein (Figure C). Because of the fistula between the pulmonary vein and esophagus, the patient underwent an emergency exploratory thoracotomy, and a 10-mm laceration in the left inferior pulmonary vein and another 15-mm laceration in the anterior esophageal wall were found during the surgery. Ultimately, the patient was diagnosed with left inferior pulmonary venous-esophageal fistula secondary to RFCA. After surgical repair and postoperative anti-infective therapy, he fully recovered and was discharged from the hospital. This case is the first report of upper gastrointestinal bleeding owing to pulmonary venous-esophageal fistula after RFCA. Previously, atrial-esophageal fistula after RFCA has been reported with an incidence of 0.04% and a mortality rate of 71% to 84%.1Cappato R. Calkins H. Chen S.A. et al.Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation.Circ Arrhythm Electrophysiol. 2010; 3: 32-38Crossref PubMed Scopus (1564) Google Scholar Fever, chest pain, gastrointestinal, and/or neurologic manifestations may develop within 3 to 38 days in patients with atrial-esophageal fistula after RFCA.2Finsterer J. Stollberger C. Pulgram T. Neurological manifestations of atrio-esophageal fistulas from left atrial ablation.Eur J Neurol. 2011; 18: 1212-1219Crossref PubMed Scopus (22) Google Scholar Thermocoagulation or electrocoagulation during the RFCA may result in focal damage to the left atrium and adjacent esophagus, which contributes to fistula formation.3Knopp H. Halm U. Lamberts R. et al.Incidental and ablation-induced findings during upper gastrointestinal endoscopy in patients after ablation of atrial fibrillation: a retrospective study of 425 patients.Heart Rhythm. 2014; 11: 574-578Abstract Full Text Full Text PDF PubMed Scopus (94) Google Scholar Nonspecific symptoms make distinguishing cardiovascular-esophageal fistula from other disorders difficult. This case suggests that in addition to routine consideration of anticoagulant agents, a cardiovascular-esophageal fistula should be suspected in patients with upper gastrointestinal bleeding after RFCA. Endoscopy and contrast-enhanced computed tomography are helpful for the diagnosis. Further analysis of clinical data from pulmonary venous-esophageal fistula and atrial-esophageal fistula are necessary to determine the clinical differences between these entities. Emergency thoracotomy and surgical repair remain life-saving treatments.
What problem does this paper attempt to address?